Abcam (ABCM) Stock Forecast, Price & News

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Abcam in the last year. There are currently 5 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" ABCM shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ABCM, but not buy additional shares or sell existing shares.
View ABCM analyst ratings or view top-rated stocks.

6 Wall Street analysts have issued 12 month target prices for Abcam's shares. Their ABCM share price forecasts range from $23.00 to $23.00. On average, they predict the company's share price to reach $23.00 in the next year. This suggests a possible upside of 1.3% from the stock's current price.
View analysts price targets for ABCM or view top-rated stocks among Wall Street analysts.

Abcam's stock was trading at $15.56 on January 1st, 2023. Since then, ABCM shares have increased by 46.0% and is now trading at $22.71.
View the best growth stocks for 2023 here.

Abcam saw a decrease in short interest during the month of August. As of August 31st, there was short interest totaling 1,790,000 shares, a decrease of 5.3% from the August 15th total of 1,890,000 shares. Based on an average trading volume of 4,320,000 shares, the days-to-cover ratio is currently 0.4 days.
View Abcam's Short Interest.

ETFs with the largest weight of Abcam (NASDAQ:ABCM) stock in their portfolio include BlackRock Future Health ETF (BMED), Invesco Nasdaq Biotechnology ETF (IBBQ) and iShares Biotechnology ETF (IBB).ProShares Ultra Nasdaq Biotechnology (BIB).

Abcam updated its earnings guidance on Tuesday, June, 27th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $525.50 million-$550.53 million.

(ABCM) raised $149 million in an initial public offering (IPO) on Thursday, October 22nd 2020. The company issued 9,000,000 shares at a price of $16.52 per share. Morgan Stanley, BofA Securities, SVB Leerink, Lazard and William Blair acted as the underwriters for the IPO.

Abcam trades on the NASDAQ under the ticker symbol "ABCM."

Abcam's stock is owned by many different institutional and retail investors. Top institutional shareholders include Durable Capital Partners LP (6.27%), Harding Loevner LP (4.66%), Brown Capital Management LLC (4.34%), Baillie Gifford & Co. (3.56%), Brown Advisory Inc. (2.84%) and Bank of New York Mellon Corp (2.27%).

Shares of ABCM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ABCM stock can currently be purchased for approximately $22.71.

Abcam (NASDAQ:ABCM) has a market capitalization of $5.21 billion and generates $379.70 million in revenue each year.

The company employs 1,760 workers across the globe.

The official website for the company is www.abcam.com. The company can be reached via phone at 44-0-12-2369-6000 or via email at investor.relations@abcam.com.